Frequency and obstetric complication of uterine leiomyoma in pregnancy
DOI:
https://doi.org/10.63682/jns.v14i32S.9979Keywords:
Antenatal Checkup, Fibroids, Leiomyoma, PregnancyAbstract
Objectives: To determine the frequency of leiomyoma in pregnant females presenting for antenatal checkup.
To determine the outcome of pregnancy complicated with leiomyoma.
Study design
Descriptive Study.: Setting This study was conducted at the Department of Obstetrics & Gynaecology, SMBBMU, Larkana, Pakistan.
Duration
Six months after the approval of the synopsis from January 31, 2023 to July 30, 2023.
Materials and methods
All patients who fulfilled the inclusion criteria and visited SMBBMU, Larkana were included in the study. Informed consent was taken after explaining the procedure, risks and benefits of the study. In our study, All the collected data were entered into the proforma attached at the end and used electronically for research purposes.
Results: The mean ± SD of age was 29.9±6.3 years. Leiomyoma was found in 49 (30.6%) women. In the distribution of complications spontaneous abortion was found in 6 (12.2%), intrauterine growth restriction in 17 (34.7%), the premature rupture of membranes was noted in 11 (22.5%) women, cesarean section in 29 (59.2%), vaginal delivery 20
(40.8%), preterm delivery 14 (28.6%) while stillbirth was noted in 5 (10.2%).
Conclusion: It is to be concluded that leiomyoma was commonly prevalent in pregnant females while cesarean section was noted as the most common leiomyoma complication followed by intrauterine growth restriction and premature rupture of membranes. More well-controlled prospective trials are needed to validate the current findings
Downloads
References
1. Donnez J, Dolmans MM. Uterine fibroid management: from the present to the future. Hum Reprod Update. 2016;22(6):665-86.
2. Vannuccini S, Clifton VL, Fraser IS, Taylor HS, Critchley H, Giudice LC, et al. Infertility and reproductive disorders: impact of hormonal and inflammatory mechanisms on pregnancy outcome. Hum Reprod Update. 2016;22(1):104-15.
3. Ortiz FM, Romero BP, Romero EP, García EE, Barraza JB, Castro EQ, et al. Miomas uterinos durante el embarazo y su repercusión en el resultado obstétrico. Ginecol Obstet Mex. 2011;79(8):467-73.
4. Zhang J, Zou B, Wang K. Spontaneous expulsion of a huge cervical leiomyoma from the vagina after cesarean: a case report with literature review. Medicine. 2018;97(33).
5. Harlev A, Wainstock T, Walfisch A, Landau D, Sheiner E. Perinatal outcome and long- term pediatric morbidity of pregnancies with a fibroid uterus. Early Hum Dev. 2019;129:33-7.
6. Pan L, Fu Z, Yin P, Chen D. Pre-existing medical disorders as risk factors for preeclampsia: an exploratory case-control study. Hypertens Pregnancy. 2019;38(4):245-51.
7. Chen Y, Lin M, Guo P, Xiao J, Huang X, Xu L, et al. Uterine fibroids increase the risk of hypertensive disorders of pregnancy: a prospective cohort study. J Hypertens. 2021;39(5):1002.
8. Chill HH, Karavani G, Rachmani T, Dior U, Tadmor O, Shushan A. Growth pattern of uterine leiomyoma along pregnancy. BMC Womens Health. 2019;19:1-5.
9. Eyong E, Okon OA. Large uterine fibroids in pregnancy with successful caesarean myomectomy. Case Rep Obstet Gynecol. 2020;2020.
10. Pérez‐Roncero GR, López‐Baena MT, Ornat L, Cuerva MJ, Garcia‐Casarrubios P, Chedraui P, et al. Uterine fibroids and preterm birth risk: A systematic review and meta‐analysis. J Obstet Gynaecol Res. 2020;46(9):1711-27.
11. Navid S, Arshad S, Meo RA. Impact of leiomyoma in pregnancy. J Ayub Med Coll Abbottabad. 2012;24(1):90-2.
12. Zhao R, Wang X, Zou L, Li G, Chen Y, Li C, et al. Adverse obstetric outcomes in pregnant women with uterine fibroids in China: a multicenter survey involving 112,403 deliveries. PloS One. 2017;12(11):e0187821.
13. Quyang DW, Norvitz ER. Management of pregnant women with leiomyomas (fibroids). 2012.
14. Qidwai G, Caughey AB, Jacoby AF. Obstetric outcomes in women with sonographically identified uterine leiomyomata. Obstet Gynecol 2006;107(2, Part 1):376–82.
15. Ouyang DW, Economy KE, Norwitz ER. Obstetric complications of fibroids. Obstet Gynecol Clin North Am 2006;33(1):153–69.
16. Exacoustòs C, Rosati P. Ultrasound diagnosis of uterine myomas and complications in pregnancy. Obstet Gynecol 1993;82(1):97–101.
17. Rice J, Kay H, Mahony B. The clinical significance of uterine leiomyomas in pregnancy. Am J Obstet Gynecol 1989;160(5 Pt 1):1212–6.
18. Levy BS. Modern management of uterine fibroids. Acta Obstet Gynecol Scand 2008;87 (8):812–23.
19. Coronado GD, Marshall LM, Schwartz SM. Complications in pregnancy, labor, and delivery with uterine leiomyomas: a population-based study. Obstet Gynecol 2000;95 (5):764–9.
20. Laughlin SK, Baird DD, Savitz DA, Herring AH, Hartmann KE. Prevalence of uterine leiomyomas in the first trimester of pregnancy: an ultrasound-screening study. Obstet Gynecol. 2009;113(3):630–5.
21. Drayer SM, Catherino WH. Prevalence, morbidity, and current medical management of uterine leiomyomas. Int J Gynaecol Obstet. 2015;131(2):117–122.
22. Donnez J, Hudecek R, Donnez O, Matule D, Arhendt HJ, Zatik J, et al. Efficacy and safety of repeated use of ulipristal acetate in uterine fibroids. Fertil Steril. 2015;103(2):519-27.
23. Wu JL, Segars JH. Is vitamin D the answer for prevention of uterine fibroids? Fertil Steril. 2015;104(3):559–60.
24. Donnez J, Vazquez F, Tomaszewski J, Nouri K, Bouchard P, Fauser BC, et al. Long-term treatment of uterine fibroids with ulipristal acetate. Fertil Steril. 2014;101(6):1565-73.
25. Medikare V, Kandukuri LR, Ananthapur V, Deenadayal M, Nallari P. The genetic bases of uterine fibroids; a review. J Reprod Infertil. 2011;12(3):181–91.
26. Islam MS, Greco S, Janjusevic M, Ciavattini A, Giannubilo SR, D’Adderio A, et al. Growth factors and pathogenesis. Best Pract Res Clin Obstet Gynaecol. 2016;34:25–36.
27. Qidwai GI, Caughey AB, Jacoby AF. Obstetric outcomes in women with sonographically identified uterine leiomyomata. Obstet Gynecol. 2006;107(2 Pt 1):376–82.
28. Ezzedine DNE. Are women with uterine fibroids at increased risk for adverse pregnancy outcome? Clin Obstet Gynecol 2016;59(1):119–27.
29. Ciavattini A, Clemente N, Delli Carpini G, Di Giuseppe J, Giannubilo SR, Tranquilli AL. Number and size of uterine fibroids and obstetric outcomes. J Matern Fetal Neonat Med. 2015;28(4):484–8.
30. Vergani P, Locatelli A, Ghidini A, Andreani M, Sala F, Pezzullo JC. Large uterine leiomyomata and risk of cesarean delivery. Obstet Gynecol. 2007;109(2 Pt 1):410–4.
31. Lai J, Caughey AB, Qidwai GI, Jacoby AF. Neonatal outcomes in women with sonographically identified uterine leiomyomata. J Maternal Fetal Neonat Med. 2012;25 (6):710–13.
32. Shavell VI, Thakur M, Sawant A, Kruger ML, Jones TB, Singh M, et al. Adverse obstetric outcomes associated with sonographically identified large uterine fibroids. Fertil Steril. 2012;97(1):107–10.
33. Lam SJ, Best S, Kumar S. The impact of fibroid characteristics on pregnancy outcome. Am J Obstet Gynecol. 2014;211(4):395.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
